Why Medicus?
Value demonstration in context
As healthcare costs rise globally, treatment value is increasingly scrutinized by payers, regulatory bodies, providers, employers, and patients. Effective value demonstration has moved from niche to necessary.
Treatment decisions are made beyond the prescription pad. With a growing number of entities influencing treatment choices at many levels, manufacturers must understand challenges and incentives across a diverse stakeholder mix.
With the growth of big data, the challenge for value demonstration in healthcare has changed from analyzing the right data to delivering actionable insights. Demonstrating value from novel, complex data sources requires innovation, creativity, and flexibility.
More and more, pricing, access, and regulatory decisions are being informed by patients’ real-world experiences. Expertise in novel evidence generation, optimal study design, and advanced analytics with real-world data are key to navigating the complexities of patients’ experiences.
We are passionate about problem-solving, and we aren’t afraid to consider novel approaches and all available data sources to provide the best answer to a question.
30+
Value must be communicated. We’re proud to have contributed to a broad set of peer-reviewed journals and industry conferences.
15+
Effective value demonstration is a moving target. We rely on extensive experience to help our clients successfully navigate a constantly changing landscape.
We take a long view when it comes to demonstrating value—our focus is on the relationship, not the project. We collaborate with clients to continuously demonstrate value over a product’s full life cycle.
We understand each challenge is unique and are committed to using innovative methods, study designs, and data sources if that’s what is needed to best help our clients generate and analyze new evidence.
Our founding principle is providing tailored support for all challenges. For each unique question our clients ask, we provide high-quality, evidence-based answers.
Successfully navigated the Institute for Clinical and Economic Review (ICER) assessment process for the first FDA-Approved directly-administered gene therapy
Evaluated value-based care initiatives using real-world date on patient support programs for a biological agent
Led the modeling for the health technology assessment process for the first highly-specialized technology recommended by NICE
Developed a novel model for Hepititis C in Japan that was published in peer-reviewed journals and used to support a health technology assessment submission
Regardless of whether challenges are immediate or years away, Medicus can help identify, demonstrate, and communicate a product’s value story.
We're eager to discuss new challenges and how we can help improve value stories.
Contact UsWe are continuously looking for teammates to strengthen and diversify our capabilities.
See openings